Mesenchymal Stromal Cells from Human Perinatal Tissues: From Biology to Cell Therapy

Overview

Journal World J Stem Cells

Publisher Baishideng Publishing Group

Date 2011 May 25

PMID 21607124

Citations 45

Authors

Karen Bieback

Irena Brinkmann

Affiliations

Soon will be listed here.

Abstract

Cell-based regenerative medicine is of growing interest in biomedical research. The role of stem cells in this context is under intense scrutiny and may help to define principles of organ regeneration and develop innovative therapeutics for organ failure. Utilizing stem and progenitor cells for organ replacement has been conducted for many years when performing hematopoietic stem cell transplantation. Since the first successful transplantation of umbilical cord blood to treat hematological malignancies, non-hematopoietic stem and progenitor cell populations have recently been identified within umbilical cord blood and other perinatal and fetal tissues. A cell population entitled mesenchymal stromal cells (MSCs) emerged as one of the most intensely studied as it subsumes a variety of capacities: MSCs can differentiate into various subtypes of the mesodermal lineage, they secrete a large array of trophic factors suitable of recruiting endogenous repair processes and they are immunomodulatory.Focusing on perinatal tissues to isolate MSCs, we will discuss some of the challenges associated with these cell types concentrating on concepts of isolation and expansion, the comparison with cells derived from other tissue sources, regarding phenotype and differentiation capacity and finally their therapeutic potential.

Citing Articles

Improvement of osteogenic differentiation potential of placenta-derived mesenchymal stem cells by metformin via AMPK pathway activation.

Manochantr S, Meesuk L, Chadee N, Suwanprateeb J, Tantrawatpan C, Kheolamai P Stem Cell Res Ther. 2024; 15(1):417.

PMID: 39533406 PMC: 11559138. DOI: 10.1186/s13287-024-04014-6.

The role of mesenchymal cells in cholangiocarcinoma.

Sueca-Comes M, Rusu E, Ashworth J, Collier P, Probert C, Ritchie A Dis Model Mech. 2024; 17(12).

PMID: 39492622 PMC: 11655028. DOI: 10.1242/dmm.050716.

Effects of dedifferentiated fat cells on neurogenic differentiation and cell proliferation in neuroblastoma cells.

Hidaka A, Uekusa S, Hosokawa T, Kaneda H, Kazama T, Hagikura K Pediatr Surg Int. 2022; 39(1):58.

PMID: 36547710 DOI: 10.1007/s00383-022-05304-x.

Human fetal membrane-mesenchymal stromal cells generate functional spinal motor neurons .

Gaggi G, Di Credico A, Guarnieri S, Mariggio M, Ballerini P, Di Baldassarre A iScience. 2022; 25(10):105197.

PMID: 36238899 PMC: 9550654. DOI: 10.1016/j.isci.2022.105197.

Umbilical Cord Mesenchymal Stem Cells Ameliorate Premature Ovarian Insufficiency in Rats.

Zhang M, Xie T, Dai W, Zhao B, Zheng Y, Hu J Evid Based Complement Alternat Med. 2022; 2022:9228456.

PMID: 35677383 PMC: 9170415. DOI: 10.1155/2022/9228456.

References

Sensebe L, Bourin P . Mesenchymal stem cells for therapeutic purposes. Transplantation. 2009; 87(9 Suppl):S49-53. DOI: 10.1097/TP.0b013e3181a28635. View

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Flores A, McKenna D, Montalban M, DE LA Cruz J, Wagner J, Bornstein R . Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion. 2008; 49(4):636-47. DOI: 10.1111/j.1537-2995.2008.02035.x. View

Tyndall A, Walker U, Cope A, Dazzi F, De Bari C, Fibbe W . Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther. 2007; 9(1):301. PMC: 1860056. DOI: 10.1186/ar2103. View

Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

Kaviani A, Perry T, Dzakovic A, Jennings R, ZIEGLER M, Fauza D . The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001; 36(11):1662-5. DOI: 10.1053/jpsu.2001.27945. View

Hildner F, Wolbank S, Redl H, van Griensven M, Peterbauer A . How chondrogenic are human umbilical cord matrix cells? A comparison to adipose-derived stem cells. J Tissue Eng Regen Med. 2009; 4(3):242-5. DOI: 10.1002/term.236. View

Zhang L, Zhang H, Hong S, Ma X, Jiang X, Xu R . Cografted Wharton's jelly cells-derived neurospheres and BDNF promote functional recovery after rat spinal cord transection. Neurochem Res. 2009; 34(11):2030-9. DOI: 10.1007/s11064-009-9992-x. View

Liu C, Hwang S . Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine. 2005; 32(6):270-9. DOI: 10.1016/j.cyto.2005.11.003. View

10.

De Coppi P, Callegari A, Chiavegato A, Gasparotto L, Piccoli M, Taiani J . Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol. 2006; 177(1):369-76. DOI: 10.1016/j.juro.2006.09.103. View

11.

Bongso A, Fong C, Gauthaman K . Taking stem cells to the clinic: Major challenges. J Cell Biochem. 2008; 105(6):1352-60. DOI: 10.1002/jcb.21957. View

12.

Tsai P, Fu T, Chen Y, Ko T, Chen T, Shih Y . The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl. 2009; 15(5):484-95. DOI: 10.1002/lt.21715. View

13.

McGuckin C, Forraz N, Baradez M, Navran S, Zhao J, Urban R . Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 2005; 38(4):245-55. PMC: 6496335. DOI: 10.1111/j.1365-2184.2005.00346.x. View

14.

Kobayashi K, Kubota T, Aso T . Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin. Early Hum Dev. 1998; 51(3):223-33. DOI: 10.1016/s0378-3782(97)00123-0. View

15.

Sarugaser R, Lickorish D, Baksh D, Hosseini M, Davies J . Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005; 23(2):220-9. DOI: 10.1634/stemcells.2004-0166. View

16.

Lee H, Lee J, Lee H, Shin J, Carter J, Sakamoto T . The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett. 2010; 481(1):30-5. DOI: 10.1016/j.neulet.2010.06.045. View

17.

Ebihara Y, Masuya M, LaRue A, Fleming P, Visconti R, Minamiguchi H . Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol. 2006; 34(2):219-29. DOI: 10.1016/j.exphem.2005.10.008. View

18.

Kim S, Han H, Chae G, Lee S, Bo S, Yoon J . Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells. 2006; 24(6):1620-6. DOI: 10.1634/stemcells.2005-0365. View

19.

Steigman S, Armant M, Bayer-Zwirello L, Kao G, Silberstein L, Ritz J . Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg. 2008; 43(6):1164-9. PMC: 2478751. DOI: 10.1016/j.jpedsurg.2008.02.052. View

20.

Mitchell K, Weiss M, Mitchell B, Martin P, Davis D, Morales L . Matrix cells from Wharton's jelly form neurons and glia. Stem Cells. 2003; 21(1):50-60. DOI: 10.1634/stemcells.21-1-50. View